Injective price has quietly become one of the strongest recovery stories in crypto over the past few months. Since the beginning of April, INJ has climbed by roughly 150%, moving from near $3 levels to around $7. Many market participants have overlooked the move because it did not happen through a single explosive breakout. The climb has been gradual and consistent, which often attracts less attention than sudden rallies.
That steady recovery becomes even more interesting when examining what has been driving the price higher.

Several developments have helped fuel the latest INJ price recovery.
One of the biggest catalysts arrived on May 7 when Injective launched native USDC and Circle’s Cross Chain Transfer Protocol. Before that update, users often relied on bridged versions of stablecoins. Native USDC and CCTP made capital movement across more than 20 blockchains much smoother. Friction during transfers dropped significantly and liquidity became easier to move throughout the ecosystem.
That upgrade helped bring fresh activity to Injective’s DeFi infrastructure and decentralized exchange ecosystem.
Another major catalyst came from Injective’s tokenomics.
The IIP 617 Supply Squeeze upgrade introduced a mechanism that directs part of dApp trading fees into recurring buyback and burn events. Demand for the program became obvious on May 6 when the monthly Community BuyBack pool filled in less than 10 minutes. Close to $200,000 worth of INJ was removed from circulation within minutes.
Supply reductions often become more noticeable when network activity increases at the same time.
Institutional developments have also entered the picture.
Binance.US introduced native INJ staking on May 29. That allows users to lock tokens and earn rewards. Fewer tokens remain available on the open market when staking participation increases.
Coinbase Financial Markets also integrated INJ into its regulated derivatives offerings during the same period. Bitnomial had already launched CFTC regulated INJ futures in April. Visibility increased further after Kraken acquired Bitnomial earlier in May.
Taken together, those developments created a combination of stronger utility, lower circulating supply, and greater institutional access.
CryptoBoss believes the current chart structure resembles a setup that previously produced one of Injective’s largest rallies.
The analyst pointed out that Injective bottomed near the $2 to $3 area during 2022 after a brutal decline. That accumulation period eventually led to a massive rally that carried INJ above $50 during the next cycle.
CryptoBoss notes that INJ recently returned to a similar historical demand zone between roughly $2.50 and $3.50 after another aggressive correction phase. Price has already rebounded from that region and now trades near $7.
A descending resistance trendline has capped rallies since the previous peak. Historical support, however, appears to be functioning as a base once again.
The analyst believes the chart may be entering a multi month accumulation phase similar to previous cycles. If that comparison continues to hold, current price levels could represent an early stage of a larger recovery process.
Related Article: Injective (INJ) Price to a New All-Time High? Here’s How It Could Happen
Third Eye examined the opportunity from a different perspective. The analyst noted that INJ recently reached $7 even though its market capitalization remains relatively small compared to many established crypto assets.
Using simple market cap comparisons, Third Eye estimated that a $1 billion valuation could place INJ near $10. Matching the valuation of SUI at roughly $3.6 billion would imply a price near $36. Reaching a valuation similar to DOGE at approximately $15.64 billion could place INJ close to $156.
The comparison focuses on relative valuation rather than chart patterns.
Third Eye argues that Injective operates a DeFi ecosystem with active infrastructure, products, and users. The analyst believes the gap between Injective’s valuation and larger crypto networks leaves room for future expansion if adoption continues growing.
Several factors now appear to be lining up for Injective. The project has introduced meaningful infrastructure upgrades. Token supply is becoming increasingly constrained through buybacks and burns. Institutional access continues expanding through regulated products and staking services.
Technical analysts are also watching a chart structure that resembles the setup that preceded Injective’s previous major rally.
Read Also: Injective (INJ) vs. Zcash (ZEC): Which Crypto Is Better to Hold in 2026?
None of these factors guarantees a new all-time high. Markets rarely move in straight lines, and broader crypto conditions will still play an important role.
What makes the current situation interesting is that both fundamentals and technical analysis are pointing toward the same narrative. Injective has already delivered a 150% recovery since April. The next challenge is whether INJ can break long-standing resistance and begin another phase of price discovery.
Subscribe to our YouTube channel for daily crypto updates, market insights, and expert analysis.
The post Injective (INJ) Price Is Back Where Its Last Mega Rally Began: Could New All-Time High Be Close? appeared first on CaptainAltcoin.


